Wednesday, June 17, 2009
In a series of recently-published
articles, a research team from the University of North Carolina at Chapel Hill
Lineberger Comprehensive Cancer Center has uncovered clues to the development of
cancers in AIDS patients.
In an April article published in the journal
PLoS Pathogens, Dirk Dittmer, Ph.D. associate professor of microbiology and
immunology at UNC's School of Medicine, demonstrated that the Kaposi sarcoma
associated herpesvirus (KSHV) is not only present in every tumor cell, but that
the cells also transcribe microRNAs (miRNA) from the virus. This represents a
collaborative effort between UNC researchers and clinicians at Beth Israel
Hospital, the University of Miami and the Federal University in Bahia, Brazil.
MicroRNAs are small molecules that regulate gene expression. Scientists
have hypothesized that viruses can cause cancer through a mechanism where the
viral genes take over the cell and induce cancerous growth through alteration of
cell miRNA, since certain kinds of miRNA are responsible for putting the
'brakes' on uncontrolled cell growth.
Dittmer's team examined samples of
tissue provided with the consent of Kaposi's sarcoma patients and found that
specific miRNA biomarkers accurately identify stages of tumor progression. They
found that certain miRNAs were lost as the tumors progressed, effectively
accelerating the cancer's growth. More aggressive tumor stages expressed higher
levels of KSHV miRNA.
In second study, published June 4 in the journal
Blood, the team looked for the presence of tumor suppressor mRNAs in primary
effusion lymphoma and Kaposi's Sarcoma.
"We chose these two cancers
because, while they are both associated with the same virus, they occur in very
different types of cells," Dittmer noted.
His team found that several
miRNAs known to suppress tumor activity were significantly less active in both
types of cancer.
"Micro RNAs are an exciting new class of cancer
markers. Knowing which ones are present in a particular tumor will help us
understand the biology and develop those micro RNAs as novel cancer therapy
targets.:"
Scientists believe that finding the mechanisms through which
viruses take over cellular systems, resulting in cancer, is a promising strategy
for cancer prevention and treatment, since it is much more feasible to block
viral infection or develop specific inhibitors of the viral genes than try to
inhibit all of the genetic changes within a cancer.
###
University of North Carolina School of Medicine